or
forgot password
  • cancer clinical trials in wenatchee, WA

  • Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Adenocarcinoma of the Extrahepatic Bile Duct, Adenocarcinoma of the Gallbladder, Adenocarcinoma With Squamous Metaplasia of the Gallbladder, Anaplastic Carcinoma of the Gallbladder, Cholangiocarcinoma of the Extrahepatic Bile Duct, Cholangiocarcinoma of the Gallbladder, Recurrent Extrahepatic Bile Duct Cancer, Recurrent Gallbladder Cancer, Unresectable Extrahepatic Bile Duct Cancer, Unresectable Gallbladder Cancer
    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Breast Cancer
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Kidney Cancer
    Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Acral Lentiginous Malignant Melanoma, Lentigo Maligna Malignant Melanoma, Nodular Malignant Melanoma, Recurrent Melanoma, Solar Radiation-related Skin Melanoma, Stage IV Melanoma, Superficial Spreading Malignant Melanoma
    Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Breast Cancer
    Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Endometrial Papillary Serous Carcinoma, Recurrent Endometrial Carcinoma
    A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
    Wenatchee Valley Medical Center - Clinical Research Department
    Wenatchee, Washington 98801
    Psoriasis
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Vorinostat and Radiation Therapy Followed By Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Pontine Glioma
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Childhood Mixed Glioma, Untreated Childhood Brain Stem Glioma
    Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Clear Cell Ovarian Cancer
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Ovarian Clear Cell Cystadenocarcinoma, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Everolimus and Octreotide With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Gastrinoma, Glucagonoma, Insulinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Pancreatic Cancer, Somatostatinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
    Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Chronic Myeloid Leukemia
    Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Esophageal Cancer, Recurrent Gastric Cancer
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Prostatic Neoplasms
    PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Lymphoma
    Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian Cancer
    Investigational Site Number 840203
    Wenatchee, Washington 98801
    Ovarian Cancer Recurrent
    S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer
    S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Breast Cancer
    Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer
    Wenatchee Valley Medical Center Wenatchee Valley
    Wenatchee, Washington 98801
    Metastatic Breast Cancer
    Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer
    Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot be Removed by Surgery
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Childhood Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer, Type 1 Papillary Renal Cell Carcinoma, Type 2 Papillary Renal Cell Carcinoma
    A Study of Brentuximab Vedotin in Adults Age 60 and Above With Newly Diagnosed Hodgkin Lymphoma (HL)
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Hodgkin Disease
    SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma
    Central Washington Hospital

    Trial Locations
    Central Washington Hospital
    Wenatchee Valley Clinic
    Melanoma (Skin)
    High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Melanoma (Skin)
    S9912 Combination Chemo in Stage III Ovarian Cancer,
    Central Washington Hospital

    Trial Locations
    Central Washington Hospital
    Wenatchee Valley Clinic
    Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer
    S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
    Central Washington Hospital

    Trial Locations
    Central Washington Hospital
    Wenatchee Valley Clinic
    Breast Cancer
    S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer
    Wenatchee Valley Clinic
    Wenatchee, Washington 98801
    Brain Tumors, Gastric Cancer, Ovarian Cancer, Prostate Cancer
    S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma
    Central Washington Hospital

    Trial Locations
    Central Washington Hospital
    Wenatchee Valley Clinic
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
    Central Washington Hospital

    Trial Locations
    Central Washington Hospital
    Wenatchee Valley Clinic
    Leukemia
    S0222: Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Lung Cancer
    S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
    Central Washington Hospital

    Trial Locations
    Central Washington Hospital
    Wenatchee Valley Clinic
    Sarcoma
    S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Central Washington Hospital

    Trial Locations
    Central Washington Hospital
    Wenatchee Valley Clinic
    Lung Cancer
    S0344 Intralesional Resection in Treating Patients With Chondrosarcoma of the Bone
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Sarcoma
    S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Head and Neck Cancer
    S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Melanoma (Skin)
    S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Breast Cancer
    S0423 Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic Chondrosarcoma
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Sarcoma
    S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
    Wenatchee Valley Medical Center
    Wenatchee, Washington 98801-2028
    Esophageal Cancer